Cue Biopharma, Inc. · NASDAQ:CUE
Meluzio Michael Vincent sold 5,628 Cue Biopharma, Inc. shares (Form 4)
Traded Aug 13, 2026 · Filed Aug 17, 2026
On Aug 13, 2026, Meluzio Michael Vincent (VP, Prin. Accounting Officer) sold 5,628 Cue Biopharma, Inc. shares at an average US$30.09 for US$169K, leaving 48,961 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 5,628 shares
- Price
- US$30.09 average (US$29.37 to US$31.13)
- Value
- US$169K
- Holding after
- 48,961 shares
- Trading plan
- No
- Role
- VP, Prin. Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | Option exercise | 13,647 | 54,589 | Direct | |
| Aug 13, 2026 | Common Stock | Sale | 1,519 | US$29.37 | 53,070 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 4,106 | US$30.35 | 48,964 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 3 | US$31.13 | 48,961 | Direct |
Source
Related
- Cue Biopharma, Inc.
- Meluzio Michael Vincent
- Cue Biopharma, Inc. shareholders
- Form 4 · Meluzio Michael Vincent · Oct 14, 2026
- Form 4 · Meluzio Michael Vincent · Jul 10, 2026
- Form 4 · Ray Sumita · Oct 14, 2026
- Form 4 · Lin Shao-Lee · Oct 14, 2026
- Schedule 13G/A · Mark E. Strome · Oct 8, 2026
- Form 4/A · Sarraf Pasha · Aug 28, 2026
- Form 4/A · Garzone Pamela · Aug 28, 2026